Title and Department
Assistant Professor of Medicine
Division of Clinical Pharmacology
Professional bio
QiPing Feng, PhD, is Assistant Professor of Medicine in the Division of Clinical Pharmacology, Department of Medicine, at Vanderbilt University Medical Center.

Dr. Feng received her bachelor’s degree from Wuhan University and Ph.D. degree from Peking Union Medical College & Chinese Academy of Medical Sciences (PUMC & CAMS) in China. She joined Vanderbilt University Medical Center as a research fellow, and then was promoted to Research Instructor and Research Assistant Professor. In 2017, her appointment was transferred to the tenure track as an Assistant Professor of Medicine.

Dr. Feng’s research focuses on the genetic analysis of lipid-lowering drugs (statins, PCSK9 inhibitors, etc.) in the context of drug outcome, pleiotropic effects, and related clinical phenotypes. Her contribution to the genetic analysis of clinical phenotypes includes defining the genetics of statin response determined from BioVU (Clinical Pharmacology Therapeutics 2013, Pharmacogenomics J 2016); identifying LPA as a predictor for residual CVD risk while on statins (Circulation 2018); elucidating the relationship between low LDL-C levels and clinical phenotypes—such as type 2 diabetes and sepsis (PLoS Med 2018, JAMA network OPEN 2019); and understanding the pleiotropy effects of statin drugs using Mendelian randomization (MR) and Phenome-wide association (PheWAS) approach (JAMA network OPEN 2021). Dr. Feng has been funded by NIH since 2016. She has authored or co-authored more than 60 publications.
Education ordered
PhD - Molecular Biology - Peking Union Medical College - 2006
Fellowship - Research, Molecular Pharma/Experimental Therapeut. - Mayo Clinic - 2010
Fellowship - Research, Clinical Pharmacology - Vanderbilt - 2012